Keywords: idec, hit, crohn, disease, antibody, put, clinical

IDEC hit as Crohn's disease antibody put on clinical hold by FDA

Article | 17 June 2002

Shares in US biotechnology firm IDEC Pharmaceuticals started to slidein after-hours trading on June 10 after the company announced that it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in